Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Rapid correction of low vitamin D status in nursing home residents 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment
Top Ten Searches
rheumatoid arthritis lupus polymyalgia sjogrens fibromyalgia amyloidosis vasculitis urate raynauds myositisYour Article Summary
Potential effects of chondroitin sulfate on joint swelling: A GAIT report
Osteoarthritis and Cartilage , 09/05/08
Hochberg MC et al. - An analysis of Glucosamine/chondroitin Arthritis Intervention Trial (GAIT) patients suggested the effect of chondroitin sulfate on joint swelling occurred more often in patients with milder pain and lower Kellgren–Lawrence Grade at entry.
Methods- GAIT- a 24-wk, double-blind randomized placebo-controlled trial comparing glucosamine, chondroitin sulfate, and the two in combination in treating knee pain in pts (n=1583) with knee OA
- Pts were randomized into placebo, glucosamine 500 mg x3/d, chondroitin sulfate 400 mg x3/d, combination in the same dosages or celecoxib 200 mg/d
- Pts on celecoxib had improvement in knee pain vs placebo
- No improvement in knee pain was seen among pts randomized to the dietary supplements
- Pts with moderate-to-severe pain receiving combination experienced some improvement
- Pts taking chondroitin sulfate had improvement in knee joint swelling
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Osteoarthritis: A review of treatment options
Geriatrics, 10/21/09
Doxycycline for osteoarthritis of the knee or hip
Cochrane Reviews, 10/23/09
Osteonecrosis of the jaw correlated to bisphosphonate therapy in non-oncologic patients: Clinicopathological features of 24 patients
Journal of Rheumatology, 11/09/09
Today in Rheumatoid Arthritis...keeping you current
Receive free subspecialty "5-minute updates" via email
Cancer risk in patients with rheumatoid arthritis treated with anti-tumor necrosis factor [alpha] therapies: Does the risk change with the time since start of treatment?
Arthritis & Rheumatism, 11/05/09
Does rheumatoid arthritis equal diabetes mellitus as an independent risk factor for cardiovascular disease? A prospective study
Arthritis Care and Research , 11/03/09
Follow-up results of 702 patients receiving tumor necrosis factor-alpha antagonists and evaluation of risk of tuberculosis
Rheumatology International, 10/26/09
Sponsor
Article Search
Sponsor


See Latest Articles


